Matthew G McDevitt insider trades: BioMed Realty Trust (BMR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 13, 2014 | BMR | ↓ Sell | 16,000 | $22.01 | $352K | Direct | Aug 13, 2014 (0d) |
| Jun 3, 2014 | BMR | ↓ Sell | 7,000 | $21.91 | $153K | Direct | Jun 3, 2014 (0d) |
| Feb 11, 2014 | BMR | ↓ Sell | 60,000 | $20.28 | $1.2M | Direct | Feb 11, 2014 (0d) |
| Nov 23, 2012 | BMR | ↓ Sell | 5,223 | $19.05 | $100K | Direct | Nov 27, 2012 (4d) |
| Jun 15, 2012 | BMR | ↓ Sell | 5,500 | $18.32 | $101K | Direct | Jun 15, 2012 (0d) |
| May 26, 2011 | BMR | ↓ Sell | 607 | $20.00 | $12K | Direct | May 31, 2011 (5d) |
| May 19, 2011 | BMR | ↓ Sell | 1,900 | $20.00 | $38K | Direct | May 23, 2011 (4d) |
| Feb 18, 2011 | BMR | ↓ Sell | 43,703 | $18.00 | $787K | By Wife | Feb 22, 2011 (4d) |
| Feb 18, 2011 | BMR | ↓ Sell | 11,200 | $18.00 | $202K | Direct | Feb 22, 2011 (4d) |
| Dec 16, 2010 | BMR | ↓ Sell | 10,000 | $17.52 | $175K | By Wife | Dec 20, 2010 (4d) |
| Jun 15, 2010 | BMR | ↓ Sell | 7,956 | $18.00 | $143K | By Wife | Jun 16, 2010 (1d) |
| Jun 14, 2010 | BMR | ↓ Sell | 9,115 | $17.39 | $159K | Direct | Jun 16, 2010 (2d) |
| Mar 11, 2010 | BMR | ↓ Sell | 20,000 | $16.73 | $335K | Direct | Mar 12, 2010 (1d) |
| Aug 10, 2009 | BMR | ↓ Sell | 17,000 | $14.04 | $239K | Direct | Aug 11, 2009 (1d) |
| Jun 15, 2009 | BMR | ↓ Sell | 44,541 | $10.07 | $449K | Direct | Jun 17, 2009 (2d) |
| Nov 22, 2006 | BMR | ↓ Sell | 5,000 | $30.23 | $151K | Direct | Nov 27, 2006 (5d) |
| Jun 15, 2006 | BMR | ↓ Sell | 11,000 | $27.83 | $306K | Direct | Jun 16, 2006 (1d) |
| Dec 16, 2005 | BMR | ↓ Sell | 10,000 | $25.05 | $250K | Direct | Dec 16, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BMR insiders
Open-market trades in the last 12 months
About Matthew G McDevitt's insider trades
Matthew G McDevitt is Executive VP, Real Estate at BioMed Realty Trust (BMR). Since Dec 16, 2005, Matthew has reported no open-market purchases and 18 sales worth $5.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), conversions (9 filings), shares withheld for taxes (6 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.